INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "HER2 TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF"

GENEVA, Nov. 3 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/054153) for "HER2 TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF" on Apr 21, 2025. With publication no. WO/2025/224598, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CLEMENTE, Goncalo dos Santos (c/o Novartis Pharma AGLichtstrasse 354056 Basel), EHARA, Takeru (c/o PeptiDream Inc.3-25-23, Tonomachi, Kawasaki-ku, Kawasaki-shiKanagawa, 210-0821), FELBER, Richard (c/o Novartis Pharma AGLichtstrasse 354056 Basel), FISCHER, Matt...